|
2020 Journal Article Going in early: hypoxia as a target for kidney disease prevention in diabetes?Barrett, Helen L., Donaghue, Kim C. and Forbes, Josephine M. (2020). Going in early: hypoxia as a target for kidney disease prevention in diabetes?. Diabetes, 69 (12), 2578-2580. doi: 10.2337/dbi20-0037 |
|
2020 Journal Article Circulating levels of the soluble receptor for AGE (sRAGE) during escalating oral glucose dosages and corresponding isoglycaemic i.v. glucose infusions in individuals with and without type 2 diabetesFotheringham, Amelia K., Bagger, Jonatan I., Borg, Danielle J., McCarthy, Domenica A., Holst, Jens J., Vilsbøll, Tina, Knop, Filip K. and Forbes, Josephine M. (2020). Circulating levels of the soluble receptor for AGE (sRAGE) during escalating oral glucose dosages and corresponding isoglycaemic i.v. glucose infusions in individuals with and without type 2 diabetes. Nutrients, 12 (10) 2928, 2928-12. doi: 10.3390/nu12102928 |
|
2020 Journal Article Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesisFlynn, Michelle C., Kraakman, Michael J., Tikellis, Christos, Lee, Man Ks, Hanssen, Nordin Mj, Kammoun, Helene L., Pickering, Raelene, Dragoljevic, Dragana, Al-Sharea, Annas, Barrett, Tessa J., Hortle, Fiona, Byrne, Frances L., Olzomer, Ellen, McCarthy, Domenica A., Schalkwijk, Casper G., Forbes, Josephine M., Hoehn, Kyle, Makowski, Liza, Lancaster, Graeme I., El-Osta, Assam, Fisher, Edward A., Goldberg, Ira J., Cooper, Mark E., Nagareddy, Prabhakara R., Thomas, Merlin C. and Murphy, Andrew J. (2020). Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis. Circulation Research, 127 (7) CIRCRESAHA.120.316653, 877-892. doi: 10.1161/CIRCRESAHA.120.316653 |
|
2020 Journal Article Prolyl hydroxylase inhibitors: a breath of fresh air for diabetic kidney disease?Forbes, Josephine M. (2020). Prolyl hydroxylase inhibitors: a breath of fresh air for diabetic kidney disease?. Kidney International, 97 (5), 855-857. doi: 10.1016/j.kint.2020.01.038 |
|
2020 Journal Article Disruption of glycogen utilization markedly improves the efficacy of carboplatin against preclinical models of clear cell ovarian carcinomaKhan, Tashbib, He, Yaowu, Kryza, Thomas, Harrington, Brittney S., Gunter, Jennifer H., Sullivan, Mitchell A., Cuda, Tahleesa, Rogers, Rebecca, Davies, Claire M., Broomfield, Amy, Gough, Madeline, Wu, Andy C., McGann, Thomas, Weroha, S. John, Haluska, Paul, Forbes, Josephine M., Armes, Jane E., Barry, Sinead C., Coward, Jermaine I., Jagasia, Nisha, Chetty, Naven, Snell, Cameron E., Lourie, Rohan, Perrin, Lewis C. and Hooper, John D. (2020). Disruption of glycogen utilization markedly improves the efficacy of carboplatin against preclinical models of clear cell ovarian carcinoma. Cancers, 12 (4) 869, 869. doi: 10.3390/cancers12040869 |
|
2020 Journal Article Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetesLe Bagge, Selena, Fotheringham, Amelia K., Leung, Sherman S. and Forbes, Josephine M. (2020). Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes. Medicinal Research Reviews, 40 (4) med.21654, 1200-1219. doi: 10.1002/med.21654 |
|
2020 Journal Article Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin DLindblom, Runa S. J., Higgins, Gavin C., Nguyen, Tuong-Vi, Arnstein, Maryann, Henstridge, Darren C., Granata, Cesare, Snelson, Matthew, Thallas-Bonke, Vicki, Cooper, Mark E., Forbes, Josephine M. and Coughlan, Melinda T. (2020). Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D. Clinical Science, 134 (2), 239-259. doi: 10.1042/CS20190787 |
|
2019 Journal Article Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agilityTan, Sih Min, Ziemann, Mark, Thallas-Bonke, Vicki, Snelson, Matthew, Kumar, Vinod, Laskowski, Adrienne, Nguyen, Tuong-Vi, Huynh, Kevin, Clarke, Michele V., Libianto, Renata, Baker, Scott T., Skene, Alison, Power, David A., MacIsaac, Richard J., Henstridge, Darren C., Wetsel, Rick A., El-Osta, Assam, Meikle, Peter J., Wilson, Scott G., Forbes, Josephine M., Cooper, Mark E., Ekinci, Elif I., Woodruff, Trent M. and Coughlan, Melinda T. (2019). Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility. Diabetes, 69 (1), 83-98. doi: 10.2337/db19-0043 |
|
2019 Journal Article Development and progression of non-alcoholic fatty liver disease: the role of advanced glycation end productsFernando, Dinali H., Forbes, Josephine M., Angus, Peter W. and Herath, Chandana B. (2019). Development and progression of non-alcoholic fatty liver disease: the role of advanced glycation end products. International Journal of Molecular Sciences, 20 (20) 5037, 5037. doi: 10.3390/ijms20205037 |
|
2019 Journal Article Genetic characterization of early renal changes in a novel mouse model of diabetic kidney diseaseBalmer, Lois A., Whiting, Rhiannon, Rudnicka, Caroline, Gallo, Linda A., Jandeleit, Karin A., Chow, Yan, Chow, Z., Richardson, Kirsty L., Forbes, Josephine M. and Morahan, G. (2019). Genetic characterization of early renal changes in a novel mouse model of diabetic kidney disease. Kidney International, 96 (4), 918-926. doi: 10.1016/j.kint.2019.04.031 |
|
2019 Journal Article Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretionZhuang, Aowen, Yap, Felicia Y. T., McCarthy, Domenica, Leung, Chris, Sourris, Karly C., Penfold, Sally A., Thallas-Bonke, Vicki, Coughlan, Melinda T., Schulz, Benjamin L. and Forbes, Josephine M. (2019). Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion. Scientific Reports, 9 (1) 13664, 13664. doi: 10.1038/s41598-019-50221-0 |
|
2019 Journal Article Glucose and glycogen in the diabetic kidney: heroes or villains?Sullivan, Mitchell A. and Forbes, Josephine M. (2019). Glucose and glycogen in the diabetic kidney: heroes or villains?. EBioMedicine, 47, 590-597. doi: 10.1016/j.ebiom.2019.07.067 |
|
2019 Journal Article Response to Letter to the Editor: "Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men"Lamb, Lydia S., Davis, Timothy M E, Forbes, Josephine, Irrgang, Felix, Golledge, Jonathan, Flicker, Leon and Yeap, Bu B. (2019). Response to Letter to the Editor: "Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men". Journal of Clinical Endocrinology and Metabolism, 104 (3), 684-685. doi: 10.1210/jc.2018-02198 |
|
2019 Journal Article The effect of a low carbohydrate formula on glycaemia in critically ill enterally-fed adult patients with hyperglycaemia: a blinded randomised feasibility trialDoola, Ra'eesa, Deane, Adam M., Tolcher, Debbie M., Presneill, Jeffrey J., Barrett, Helen L., Forbes, Josephine M., Todd, Alwyn S., Okano, Satomi and Sturgess, David J. (2019). The effect of a low carbohydrate formula on glycaemia in critically ill enterally-fed adult patients with hyperglycaemia: a blinded randomised feasibility trial. Clinical Nutrition ESPEN, 31, 80-87. doi: 10.1016/j.clnesp.2019.02.013 |
|
2018 Journal Article Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older MenLamb, Lydia S., Alfonso, Helman, Norman, Paul E., Davis, Timothy M. E., Forbes, Josephine, Müench, Gerald, Irrgang, Felix, Almeida, Osvaldo P., Golledge, Jonathan, Hankey, Graeme J., Flicker, Leon and Yeap, Bu B. (2018). Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men. Journal of Clinical Endocrinology and Metabolism, 103 (11), 4224-4231. doi: 10.1210/jc.2018-00674 |
|
2018 Journal Article RAGE deletion confers renoprotection by reducing responsiveness to transforming growth factor-β and increasing resistance to apoptosisHagiwara, Shinji, Sourris, Karly, Ziemann, Mark, Tieqiao, Wu, Mohan, Muthukumar, McClelland, Aaron D, Brennan, Eoin, Forbes, Josephine, Coughlan, Melinda, Harcourt, Brooke, Penfold, Sally, Wang, Bo, Higgins, Gavin, Pickering, Raelene, El-Osta, Assam, Thomas, Merlin C, Cooper, Mark E and Kantharidis, Phillip (2018). RAGE deletion confers renoprotection by reducing responsiveness to transforming growth factor-β and increasing resistance to apoptosis. Diabetes, 67 (5), 960-973. doi: 10.2337/db17-0538 |
|
2018 Journal Article Diabetes-specific formulae versus standard formulae as enteral nutrition to treat hyperglycemia in critically ill patients: protocol for a randomized controlled feasibility trialDoola, Ra'eesa, Todd, Alwyn S., Forbes, Josephine M., Deane, Adam M., Presneill, Jeffrey J. and Sturgess, David J. (2018). Diabetes-specific formulae versus standard formulae as enteral nutrition to treat hyperglycemia in critically ill patients: protocol for a randomized controlled feasibility trial. JMIR Research Protocols, 7 (4) e90, e90. doi: 10.2196/resprot.9374 |
|
2018 Journal Article Mitochondrial dysfunction and signalling in diabetic kidney disease: oxidative stress and beyondFlemming, Nicole Bernadette, Gallo, Linda Alba and Forbes, Josephine Maree (2018). Mitochondrial dysfunction and signalling in diabetic kidney disease: oxidative stress and beyond. Seminars in Nephrology, 38 (2), 101-110. doi: 10.1016/j.semnephrol.2018.01.001 |
|
2018 Journal Article Mitochondrial dysfunction in diabetic kidney diseaseForbes, Josephine M. and Thorburn, David R. (2018). Mitochondrial dysfunction in diabetic kidney disease. Nature Reviews. Nephrology, 14 (5), 291-312. doi: 10.1038/nrneph.2018.9 |
|
2018 Journal Article Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patientsDoola, Ra'eesa, Greer, Ristan M., Hurford, Rod, Flatley, Christopher, Forbes, Josephine M., Todd, Alwyn S., Joyce, Chris J. and Sturgess, David J. (2018). Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients. Clinical Nutrition, 38 (4), 1707-1712. doi: 10.1016/j.clnu.2018.08.001 |
